Kinnos, a New York-based startup that specializes in developing disinfection products for hospitals, has secured an additional $15 million in funding to ensure effective disinfection of hospital surfaces. The funding round was led by Morningside Ventures, with participation from existing investors, including Y Combinator and Sinai Ventures.<\/p>\n
The COVID-19 pandemic has highlighted the importance of maintaining a clean and safe environment in hospitals. Hospitals are high-risk areas for the spread of infectious diseases, and disinfection is critical to prevent the transmission of pathogens. Kinnos has developed a unique disinfection technology called Highlight, which uses a color additive to ensure complete coverage of surfaces during the disinfection process.<\/p>\n
Highlight is a patented technology that uses a color additive to ensure that surfaces are completely covered during the disinfection process. The color additive is added to the disinfectant solution, and when the solution is applied to a surface, it turns blue. This allows the user to see where the disinfectant has been applied and ensures that all areas are covered.<\/p>\n
The technology has been tested and validated by leading hospitals and research institutions, including the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). Highlight has been shown to be effective against a wide range of pathogens, including COVID-19, MRSA, and C. difficile.<\/p>\n
Kinnos was founded in 2014 by three Columbia University graduates who were inspired by the Ebola outbreak in West Africa. They saw firsthand the challenges of disinfecting hospitals and decided to develop a solution that would make the process more effective and efficient.<\/p>\n
The company has already raised $6 million in funding from investors, including Y Combinator and Sinai Ventures. With the additional $15 million in funding, Kinnos plans to expand its product line and increase its sales and marketing efforts.<\/p>\n
Kinnos’ Highlight technology has the potential to revolutionize the way hospitals approach disinfection. By ensuring complete coverage of surfaces, hospitals can reduce the risk of infection and improve patient outcomes. The additional funding will allow Kinnos to continue to develop innovative solutions that help hospitals maintain a clean and safe environment.<\/p>\n
Kinnos, a New York-based startup that specializes in developing disinfection products for hospitals, has secured an additional $15 million in funding to ensure effective disinfection of hospital surfaces. The funding round was led by Morningside Ventures, with participation from existing investors, including Y Combinator and Sinai Ventures. The COVID-19 pandemic has highlighted the importance of […]<\/p>\n","protected":false},"author":2,"featured_media":2527034,"menu_order":0,"template":"Default","format":"standard","meta":[],"aiwire-tag":[3514,2880,279,12616,789,11,441,342,213,1150,132,18,3527,2156,20,649,23,368,5214,29,218,219,11021,4500,13710,2170,2014,5849,9007,12451,222,3210,2175,37,2913,7782,9022,5483,5484,2562,2185,156,157,1780,7174,9709,28713,997,531,40,1198,235,7190,376,377,162,1206,10102,50,240,51,52,15288,3350,4230,245,2809,5116,1027,8780,13377,4673,169,57,389,170,12638,22962,1427,5867,12904,2594,172,60,61,62,291,292,1054,2960,5055,178,1344,1659,69,1252,13267,179,6304,8554,75,23309,5454,2241,2032,9478,6906,489,355,5,10,7,8,82,5287,6944,299,629,1813,702,191,192,1361,268,412,1549,413,774,11563,2986,4566,199,200,5604,4219,274,840,10441,204,8499,108,109,1720,111,18598,3931,117,1471,210,211,7523,2043,361,9,1857,27583,435,1838,311,2769,7170,124,125,920,4214,6],"aiwire":[2122],"_links":{"self":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2541189"}],"collection":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire"}],"about":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/types\/platowire"}],"author":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":0,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2541189\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media\/2527034"}],"wp:attachment":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media?parent=2541189"}],"wp:term":[{"taxonomy":"aiwire-tag","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire-tag?post=2541189"},{"taxonomy":"aiwire","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire?post=2541189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}